Takeda M, Hashimoto R, Kudo T, Okochi M, Tagami S, Morihara T, Sadick G, Tanaka T. Laughter and humor as complementary and alternative medicines for dementia patients. BMC Complement Altern Med. 2010; 10 :28. doi: 10.1186/1472-6882-10-28. [ Cross Ref ]...
Informal carers’ perspectives on the delivery of acute hospital care for patients with dementia: a systematic review with dementia in the acute hospital setting and highlights important areas to address to improve the experience of an admission for both carer and patient... S Beardon,K Patel,B...
Reflections on caring for parents with dementia Philip A. Masters, MD Reflections of an aging physician Philip A. Masters, MD Doctors can get angry, too Philip A. Masters, MD Related Posts Patients turn to GoFundMe when money and hope run out ...
People with dementia, especially those living in residential aged care facilities (RACFs), are at particularly high risk of medication harm. We sought to describe medications prescribed for a sample of people with dementia living in RACFs.A total of 351 residents with dementia aged over 65 ...
Alternative medicines may have potential beneficial results in treating certain forms of dementia and related symptoms, as well as slowing disease progression. Alternative medicines may ameliorate disturbances in cognition, mood, sleep and activities of daily living. Primary mechanisms of action include mod...
FullText Seasons change, fashions change, US presidents change, but for many patients, prescriptions never do—except to become more numerous. Among US adults aged 40 to 79 years, about 22% reported using 5 or more prescription drugs in the previous 30 days, according todatafrom t...
While there have recently been a number of oncology drugs suitable for the treatment of cancers in the elderly, there has been a lack of any new treatments for dementia, congestive heart failure, and the management of chronic pain in this population. Graham McClelland, PhD, is a...
Dementia Alzheimer’s drug approved by UK regulator but too costly for NHS Spending watchdog declines to give green light to lecanemab for patients in England August 8 2024 Medical science NHS in England to roll out £1.7mn Crispr gene editing drug ...
The move comes after the US Food and Drug Administration approved the drug for US patients last year. Thousands of Alzheimer’s patients have already received Leqembi infusions in the US, with the drug projected to generate $154mn in revenue worldwide this year, almost all from the US, acco...
Complementary and alternative medicines in the treatment of dementia: an evidence-based review. Alternative medicines may have potential beneficial results in treating certain forms of dementia and related symptoms, as well as slowing disease progress... Bruce,Diamond,Susan,... - 《Drugs & Aging》 ...